Newsbenzinga
Jade Biosciences Says Dermatomyositis Candidate JADE301 Showed About 25-Day Half-Life In Primates; Expects Phase 1 Start In Q4 2026
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Comments —
Loading comments…